Tvardi Therapeutics Ownership | Who Owns Tvardi Therapeutics?

Tvardi Therapeutics Ownership Summary

Tvardi Therapeutics is owned by 9.60% institutional investors, 27.53% insiders, and 62.87% retail investors. Slate path capital lp is the largest institutional shareholder, holding 7.53% of TVRD shares.

TVRD Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Tvardi Therapeutics	9.60%	27.53%	62.87%
Sector	Healthcare Stocks	488.17%	11.08%	-399.26%
Industry	Biotech Stocks	306.59%	11.10%	-217.69%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Slate path capital lp	704.12K	7.53%	$16.43M
Blackrock funding, inc. /de	267.88K	2.86%	$6.25M
683 capital management	176.03K	1.88%	$3.63M
Farallon capital management	43.23K	0.46%	$1.01M
Marshall wace, llp	24.98K	0.27%	$582.78K
Barclays	5.79K	0.06%	$135.00K
Headlands	3.43K	0.04%	$80.05K
Srs capital advisors	867.00	0.01%	$20.23K
Sterling capital management	82.00	0.00%	$1.91K
Raymond james financial	65.00	0.00%	$1.52K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Slate path capital lp	704.12K	0.28%	$16.43M
683 capital management	176.03K	0.24%	$3.63M
Headlands	3.43K	0.01%	$80.05K
Farallon capital management	43.23K	0.00%	$1.01M
Srs capital advisors	867.00	0.00%	$20.23K
Marshall wace, llp	24.98K	0.00%	$582.78K
Blackrock funding, inc. /de	267.88K	0.00%	$6.25M
Mcilrath & eck	20.00	0.00%	$467.00
Trust co of toledo na /oh/	9.00	-	$210.00
Sterling capital management	82.00	-	$1.91K

Top Buyers

Holder	Shares	% Assets	Change
Slate path capital lp	704.12K	0.28%	704.12K
Blackrock funding, inc. /de	267.88K	0.00%	267.88K
683 capital management	176.03K	0.24%	176.03K
Farallon capital management	43.23K	0.00%	43.23K
Marshall wace, llp	24.98K	0.00%	24.98K

Top Sellers

Holder	Shares	% Assets	Change
Sound income strategies	2.00	-	2.00
Truvestments capital	4.00	-	4.00
Trust co of toledo na /oh/	9.00	-	9.00
Mai capital management	10.00	-	10.00
Harbour investments	14.00	-	14.00

New Positions

Holder	Shares	% Assets	Change	Value
Slate path capital lp	704.12K	0.28%	704.12K	$16.43M
Blackrock funding, inc. /de	267.88K	0.00%	267.88K	$6.25M
683 capital management	176.03K	0.24%	176.03K	$3.63M
Farallon capital management	43.23K	0.00%	43.23K	$1.01M
Marshall wace, llp	24.98K	0.00%	24.98K	$582.78K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	30	-	897,987	-	9	-	30	-	-	-

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-

TVRD Ownership FAQ

Who Owns Tvardi Therapeutics?

Tvardi Therapeutics shareholders are primarily institutional investors at 9.60%, followed by 27.53% insiders and 62.87% retail investors. The average institutional ownership in Tvardi Therapeutics's industry, Biotech Stocks , is 306.59%, which Tvardi Therapeutics falls below.

Who owns the most shares of Tvardi Therapeutics?

Tvardi Therapeutics’s largest shareholders are Slate path capital lp (704.12K shares, 7.53%), Blackrock funding, inc. /de (267.88K shares, 2.86%), and 683 capital management (176.03K shares, 1.88%). Together, they hold 12.27% of Tvardi Therapeutics’s total shares outstanding.

Does Blackrock own Tvardi Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Tvardi Therapeutics.

Who is Tvardi Therapeutics’s biggest shareholder by percentage of total assets invested?

Slate path capital lp is Tvardi Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.28% of its assets in 704.12K Tvardi Therapeutics shares, valued at 16.43M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools